Brief: Prime Medicine, Inc. FY EPS USD -1.35
03/03/2026 13:00
Mar 03 (Reuters) - Prime Medicine, Inc. FY operating expenses USD 212.982 million. FY income from operations USD -208.35 million FY net income USD -201.142 million
Recent news on Prime Medicine
See all newsBrief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm647 In Alpha-1 Antitrypsin Deficiency
Prime Medicine, Inc. reports results for the quarter ended June 30 - Earnings Summary
Prime Medicine Q2 net loss narrows on lower expenses
Brief: Prime Medicine, Inc. Q2 EPS USD -0.24
Brief: Prime Medicine Announces U.S. FDA Clearance Of Investigational New Drug Application For Pm577a In H1069q-Mutated Wilson Disease